Past week, you may possibly have seen that Puma Biotechnology, Inc. (NASDAQ:PBYI) released its to start with-quarter consequence to the...
Puma
ParticipantsMariann Ohanesian; IR; Puma Biotechnology, Inc.Alan Auerbach; CEO, President & Chairman of the Board; Puma Biotechnology, Inc.Jeff Ludwig; Chief Commercial...
LOS ANGELES--(Business WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical organization, declared the poster presentation of a Phase I/II demo of...
Key Insights Specified the substantial stake in the stock by institutions, Puma Biotechnology's stock value could be susceptible to their...
LOS ANGELES--(Business enterprise WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that on July 1, 2022, the Payment Committee...
Puma Biotechnology (NASDAQ:PBYI - Get Rating)'s stock had its "buy" rating restated by stock analysts at HC Wainwright in a...
